Merck & Co., Inc. (MRK): A Bull Case Theory
We came across a bullish thesis on Merck & Co., Inc. (MRK) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.
Merck Sharp & Dohme Corp. (MRK)
Market is closed
Sector: Pharmaceutical Preparations
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.22 | 550 | Director | 750 | 2006-01-18 | Filing | |
| $45.65 | 200 | Director | 200 | 2002-09-24 | Filing |
News See All
9 Stocks on Jim Cramer’s Radar
Jim Cramer, host of Mad Money, recently emphasized the importance of long-term investing, urging investors to focus on the growth prospects of certain pharmaceutical stocks while also answering callers...
15 Best Cheap Stocks to Buy for 2025
The U.S. consumer prices report released this week revealed a less-than-expected increase in December, signaling a potential cooling in inflation pressures.
13 Highest Yielding Dividend Stocks in the Dow
The Dow Jones Industrial Average, or simply the Dow, is one of the most well-known and influential stock market indices globally.
Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks
In one of his latest appearances on CNBC's Squawk on the Street, Jim Cramer started the morning by commenting on the latest Producer Price Index (PPI) release.
Jim Cramer Discussed These 21 Stocks As Bond Yields Soared
In a recent episode of CNBC's Squawk On The Street, Jim Cramer started out by commenting on quantum computing stocks.
12 Most Reliable Dividend Stocks To Buy According to Hedge Funds
The year 2024 proved favorable for dividends, even though the Dividend Aristocrats Index lagged behind the broader market.
Jim Cramer Discussed These 29 Stocks Ahead Of Major AI Event
In his appearance on Squawk on the Street the day CES took place in Las Vegas, Jim Cramer commented on the stock market division that persisted throughout 2024 and is present in 2025 as well.
13 Best Pharma Dividend Stocks To Buy In 2024
The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, reflecting a shift toward smaller, more strategic transactions.
8 Best Low Volatility Stocks To Buy Right Now
The market has shown strong performance overall, with the S&P 500 up nearly 26% year to date. However, in the past thirty days, it has experienced a slight decline of 1%.
Billionaire Hedge Funds
